Roche Holding (SWX:ROP) received FDA approval for its Elecsys pTau217 blood test for Alzheimer's disease in the U.S. The ...
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced two new developments for its ...
Key Investor Takeaways ・Roche (USOTC:RHHBY) launched two new research-use PCR assays to expand its cyclospora testing portfolio. ・The new tests provide laboratories with additional platform and panel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results